CN1058165C - Chinese drugs for curing hepatitis B - Google Patents

Chinese drugs for curing hepatitis B Download PDF

Info

Publication number
CN1058165C
CN1058165C CN95116034A CN95116034A CN1058165C CN 1058165 C CN1058165 C CN 1058165C CN 95116034 A CN95116034 A CN 95116034A CN 95116034 A CN95116034 A CN 95116034A CN 1058165 C CN1058165 C CN 1058165C
Authority
CN
China
Prior art keywords
radix
rhizoma
fructus
medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95116034A
Other languages
Chinese (zh)
Other versions
CN1136939A (en
Inventor
卢颖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN95116034A priority Critical patent/CN1058165C/en
Publication of CN1136939A publication Critical patent/CN1136939A/en
Application granted granted Critical
Publication of CN1058165C publication Critical patent/CN1058165C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a medicine with the effective cure rate of 100% for treating viral hepatitis B and a processing and preparing technology thereof for a honeyed bolus, syrup and a capsule for the medicine. The medicine is prepared from the following raw materials: milkvetch root, ginseng, largehead atractylodes rhozome, tuckahoe, bupleurum root, white peony alba, immature orange fruit, curcuma root, red sage root, turtle shell, sphene, alum, Chinese magnolivine fruit, euchresta japonica, giant knotweed rhizome, airpotato yam rhizome, chicken's gizzard-membrane, malt, hawthorn fruit, rhubarb and yeast; the raw materials are respectively crushed into 120-mesh fine powder according to the requirements of different pharmaceutical dosage forms or concentrated solution is extracted by decoction with water; old vinegar, ginger juice and white granulated sugar are added, and the mixture is prepared into a honeyed bolus, syrup and a capsule in proportion. The present invention has the advantages of precise and appropriate formula, novel production, convenient administration, abundant medicine source, low price and no toxic or side effect, and the therapeutic efficacy of the present invention keeps a leading place.

Description

A kind of Chinese medicine preparation for the treatment of hepatitis B and preparation method thereof
The present invention relates to the medicine of the hundred-percent treatment hepatitis B of a kind of effective cure rate.It is to be the compound Chinese patent medicine of raw material outfit manufacturing by the multiple genuine Chinese medicine of selecting out among the Chinese medicine group.
The invention still further relates to this medicine honeyed pill, syrup, capsular processing and preparation method.
Hepatitis B is a kind of chronic infectious disease by the deficient initiation of body disease-resistant immunologic function.Hepatitis B virus (HBV) is though be its main source of disease body that brings out, and body disease-resistant regulating power and immune sterilizing function are deficient, and particularly local to carry out regulation and control association function deficient is that the basis with development takes place whole pathological changes to liver.After HBV infects human body, if body disease-resistant regulating power and immune sterilizing function prosperity have enough strength to eliminate evocating substances such as removing HBV, just pathological changes can not take place.Otherwise HBV etc. discharge the excitation factor at the collaborative fused down of affine guiding material in infected cell, and it is hyperfunction to bring out the liver function antagonism, causes a series of inflammatory reactions.Because the liver function antagonism is hyperfunction.Synthetic and corresponding the increasing of release of material, with the passing of time then alluvial gradually causes the passages through which vital energy circulates pipeline to be obstructed, to conclude swollen tissue.Have in view of that, it is deficient that the whole pathological process of hepatitis B can summarize endogenous cause of ill, exopathogenic factor virus, and pathogenesis is not from general character such as alluvials.Fuan is healthy and free from worry to be that main purpose designs to restrain above-mentioned general character.
For the treatment of hepatitis B, the countries in the world experts and scholars are seeking good method, have paid hard work.Up to the present, can only lack the good plan that makes an initiative sally based on passive Supporting Therapy.Though clinical have antiviral therapy, immune modulating treatment, anti-infective therapy, liver protection treatment, a hormone therapy etc., curative effect is unsatisfactory, exists much to be difficult to the problem that solves.
1, HBV is difficult to eliminate removing, and the virus signature thing positive is difficult for turning out cloudy property;
2, the reparation difficulty of hepatic tissue infringement, fibrosclerosis easily, and even canceration;
3, symptom and sign and index such as chemical examination detections etc. the impermanence of bounce in therapeutic process, relapse rate is a hundred per cent almost.
The Chinese medicine hepatitis B presents the gratifying symptom of a trend, to liver function to resume treatment effect more satisfactory, after treatment, the abnormal liver function index all has recovery in various degree normal.But the solution to an above-mentioned difficult problem still makes little progress.
Drug therapy hepatitis B of the present invention not only can be recovered disease-resistant regulating power of enhancing body and immune sterilizing function.And can improve infected cell self identification dissident, eliminate the ability of removing viruses such as HBV.This medicine has inhibitory or killing effect to HBV, not only hepatic tissue and function is not had any injury, and can protect and repair damaged tissue and function to greatest extent, promotes that pathological changes reverses fast.Again can the dredging the meridian pipeline, improve the liver material circulation, dissolve material alluvial swelling.Promote the supply of the nutrition energy to liver, the softening fibre sclerosis activates Telatrophy.Not only can eliminate the joint that is staggered to form because of hepatic tissue swelling and atrophy and tie concavo-convex focus, control sclerosis canceration.And can improve the physiological function that the local execution regulation and control of liver association function promotes to excite other internal organs by reparation, fundamentally cure hepatitis B, never recurrence after healing.
The purpose of this invention is to provide a kind of various types of hepatitis B patients that are widely used in, can eliminate viruses such as removing HBV effectively, the virus signature thing positives such as HBsAg, HBeAg, HBcAb are turned out cloudy.Promote damaged tissue and function to quicken to repair, improve fibrosclerosis, stop carcinous cancerating, fundamentally cure hepatitis B, the Chinese patent medicine compound preparation that never recurs after healing.
Second purpose of the present invention provides processing outfit and the manufacture method that the healthy and free from worry medicine honeyed pill in Fuan, syrup, glue such as assist at medicinal preparation for oral administration.
Design of the present invention is: deficient according to the hepatitis B endogenous cause of ill, exopathogenic factor virus, pathogenesis is the general character of high alluvial not, application traditional Chinese medical science macroscopic view is debated crux and is closed the method that the doctor trained in Western medicine microcosmic is debated disease, therefrom select out tonify deficiency in the Drug Storage for a post and treat damage, but kill the virus, dissolve alluvial and wait the superior medicine of effect, be combined into the Chinese patent medicine of high-efficiency reliable treatment hepatitis B.
Optimum formula components by weight part of medicine of the present invention is:
The Radix Astragali 100 Radix Ginsengs 60 Rhizoma Atractylodis Macrocephalaes 60 Poria 60
Radix Bupleuri 100 Radix Paeoniae Albas 60 Fructus Aurantii Immaturuss 60 Radix Curcumaes 60
Radix Salviae Miltiorrhizae 100 Carapax Trionycis 60 Sal Nitri 60 Alumen 60
Fructus Schisandrae Chinensis 100 Radix Sophorae Tonkinensiss 60 Rhizoma Polygoni Cuspidati 60 Rhizoma Dioscoreae Bulbiferaes 60
Endothelium Corneum Gigeriae Galli 100 Fructus Hordei Germinatus 60 Fructus Crataegis 60 Radix Et Rhizoma Rhei 60
Yeast 100
Minimum formulation components by weight part of medicine of the present invention is:
The Radix Astragali 100 Radix Ginsengs 45 Rhizoma Atractylodis Macrocephalaes 45 Poria 60
Radix Bupleuri 90 Radix Paeoniae Albas 45 Fructus Aurantii Immaturuss 60 Radix Curcumaes 45
Radix Salviae Miltiorrhizae 90 Carapax Trionycis 45 Sal Nitri 30 Alumen 30
Fructus Schisandrae Chinensis 60 Radix Sophorae Tonkinensiss 45 Rhizoma Polygoni Cuspidati 60 Rhizoma Dioscoreae Bulbiferaes 45
Endothelium Corneum Gigeriae Galli 100 Fructus Hordei Germinatus 60 Fructus Crataegis 60 Radix Et Rhizoma Rhei 45
Yeast 60
Maximum constraints recipe ingredient weight ratio part of medicine of the present invention is:
The Radix Astragali 150 Radix Ginsengs 100 Rhizoma Atractylodis Macrocephalaes 120 Poria 150
Radix Bupleuri 150 Radix Paeoniae Albas 90 Fructus Aurantii Immaturuss 120 Radix Curcumaes 100
Radix Salviae Miltiorrhizae 150 Carapax Trionycis 100 Sal Nitri 60 Alumen 60
Fructus Schisandrae Chinensis 150 Radix Sophorae Tonkinensiss 100 Rhizoma Polygoni Cuspidati 150 Rhizoma Dioscoreae Bulbiferaes 100
Endothelium Corneum Gigeriae Galli 200 Fructus Hordei Germinatus 200 Fructus Crataegis 120 Radix Et Rhizoma Rhei 90
Yeast 150
The processing and preparation method of thing medicine honeyed pill of the present invention is:
1, all medicines are given birth to usefulness, needn't any infusion;
2, get Rhizoma Zingiberis Recens and mash, 50 milliliters of extracting juice of extruding are standby;
3, the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, Radix Et Rhizoma Rhei are processed into coarser powder by well-established law, mix with Sal Nitri, Alumen, yeast and to mix thoroughly, be ground into 120 order fine powders;
4, with 25 milliliters in mature vinegar, 50 milliliters of Rhizoma Zingiberis Recens juice mix with above-mentioned medicated powder to be mixed thoroughly, puts into wooden case, builds case lid, ferments 3 days;
5, take out medicated powder after three days, take out after 90 minutes, make honeyed pill by well-established law-12 ℃ of cold preservations.Every ball weighs 12 grams.
The processing and preparation method of medical syrup of the present invention is:
1, all medicines are given birth to usefulness, needn't any infusion;
2, get Rhizoma Zingiberis Recens and mash, 30 milliliters of extracting juice of extruding are standby;
3, the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Radix Et Rhizoma Rhei, Fructus Crataegi are processed into decoction pieces by well-established law, mix with Sal Nitri, Alumen, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, yeast and put into the sand jar and decoct with water three times.For the first time add water and cross 6 centimetres of powder, boil 90 minutes, taking-up medicinal liquid; For the second time add water and cross 4 centimetres of powder, boiled 60 minutes, take out medicinal liquid; Add water for the third time and cross 2 centimetres of powder, boiled 30 minutes, take out medicinal liquid;
4, the medicinal residues after will decocting are mashed as mud, mix with three medicinal liquids and mix thoroughly, filter twice with two layers of hospital gauze, and with 20 milliliters in mature vinegar, 30 milliliters of Rhizoma Zingiberis Recens juice are put into marmite, and first intense fire, back slow fire are concentrated into every milliliter and contain 1 and restrain the crude drug amount;
5, the white sugar that adds every milliliter 1 gram content is while hot mixed thoroughly, is filtered, and makes nourushing syrup.
The processing and preparation method of medicament capsule of the present invention is:
1, all medicines are given birth to usefulness, needn't any infusion;
2, get Rhizoma Zingiberis Recens and mash, 20 milliliters of extracting juice of extruding are standby;
3, get 1/2 of the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Alumen, Sal Nitri, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, each plant demand of Radix Et Rhizoma Rhei, the yeast consumption all mixes to be mixed thoroughly, is ground into 120 order fine powders;
4,1/2 decocting with the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Alumen, Sal Nitri, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, wheat medicine, Fructus Crataegi, each plant demand of Radix Et Rhizoma Rhei boils three times.For the first time add water and cross 6 centimetres of powder, boiled 90 minutes, take out medicinal liquid; For the second time add water and cross 4 centimetres of powder, boiled 60 minutes, take out medicinal liquid; Add water for the third time and cross 2 centimetres of powder, boiled 30 minutes, take out medicinal liquid;
5, mix three medicinal liquids, with 20 milliliters in mature vinegar, Rhizoma Zingiberis Recens juice is mixed thoroughly, is filtered for 20 milliliters;
6, medicinal liquid is poured in the medicated powder mixed thoroughly, pack in the sand jar, build cover.The sand jar is put into steamer, add water in the pot, the depth of water is with submergence sand jar 2/3 degree of being.Boiled 60-90 minute.Should note not allowing water immerse in the sand jar during steaming and decocting;
7, get clearance pot after the truce cooling, medicated powder is taken out in the sand jar, after-12 ℃ of freeze-drying lyophilizations, incapsulate by well-established law.Every capsule 0.5 gram.
Drug therapy hepatitis B adult's of the present invention consumption and instructions of taking are;
1, honeyed pill: each 12 grams, every day 3 times, eliminating cold for resuscitation aquation clothes after meal.Child and old person's consumption cut down according to the circumstance;
2, syrup: each 15 milliliters, every day 3 times, directly oral after meal.Child and old person's consumption cut down according to the circumstance;
3, capsule: each 10 grams, every day 3 times, warm water delivery service after meal.Child and old person's consumption cut down according to the circumstance.
Drug study of the present invention studies have shown that following pharmacological action:
1, strengthens hypophysis cerebri---adrenal cortex function, adjust the substance in vivo balance, improve the body disease-resistant regulating power;
2, excite T, bone-marrow-derived lymphocyte and NK cell activity, promote the generation and the function of specific immunity, improve infected cell recognition, separation, eliminating dissident's ability;
3, bring out interferon, improve the sensitivity that cell utilizes interferon, eliminate effectively and eliminate HBV etc. and bring out virus;
4, improve circulation, promote of the supply of the nutrition energy liver.Can hepatoprotective, enzyme falls.Improve serum albumin, reduce globulin;
5, promote to be compromised effective reparation of tissue and function, the joint knot shape of eliminating hepatic tissue alluvial swelling and sclerosis alternative form cancerates;
6, improve organism quality, strengthen the internal organs physiological function, fundamentally cure hepatitis B, no longer recurrence after healing.
Drug therapy hepatitis B of the present invention is declared into having used more than two decades, has obtained the hundred-percent ideal effect of effective cure rate.Be to confirm clinical effectiveness, the hepatitis B 876 routine clinical data adjustment report of the receipts of freight and miscellany that now will use the healthy and free from worry treatment in Fuan separately as after.Take medicine honeyed pill therapist 322 examples of the present invention and be the honeyed pill group, take medical syrup therapist 290 examples of the present invention and be the syrup group, take medicament capsule therapist 264 examples of the present invention and be Capsules group.Honeyed pill group male 224 examples, women's 98 examples, age reckling 15 years old, the oldest person 64 years old.Syrup group male 206 examples, women's 84 examples; Age reckling 1.5 years old; The oldest person 65 years old.Capsules group male's 201 examples, women's 63 examples, age reckling 18 years old, the oldest person 58 years old.All cases all meet the diagnostic criteria that national virus type hepatitis meeting is formulated in Shanghai May nineteen ninety.
Method of administration: each 12 grams of honeyed pill group, every day 3 times, eliminating cold for resuscitation aquation clothes after meal.Child and old person's consumption cut down according to the circumstance.Each 15 milliliters of syrup group, every day 3 times, directly oral after meal.Child and old person's consumption cut down according to the circumstance.Each 10 grams of Capsules group, every day 3 times, warm water delivery service after meal.Child and old person's consumption cut down according to the circumstance.
Observation item:
1, degree is alleviated in the elimination of symptom and sign;
2, liver function index: serum total bilirubin (TBTL); Serum glutamic pyruvic transminase (ALT reitman-frankel method); Serum alkaline phosphatase (AKP King's method); Serum albumin egg (A); Globulin (G); Alpha-fetoprotein (AFP).
3, virus signature thing: HBsAg, HBeAg, HBcAb, DNA.
The result:
1,622 examples are all eliminated in symptom and sign treatment back, account for 70.8%; SPR 121 examples account for 13.8%, and part is alleviated 133 examples, accounts for 15.3%.The elimination alleviation degree of each group treatment back symptom and sign sees Table 1.
Degree is alleviated in the elimination of each group treatment back symptom of table 1 and sign
Group Total routine number All eliminate The most of disappearance Part is alleviated
Example ％ Example ％ Example ％
The honeyed pill group 322 246 74.2 60 18.6 16 7.2
The syrup group 290 211 72.6 29 10 50 17.4
Capsules group 264 165 62.4 32 12 67 25.6
2, liver function index: unusual 133 examples of TBTL before the treatment, normal 130 examples are recovered in the treatment back, account for 97.7%; Unusual 392 examples of ALT before the treatment, normal 386 examples are recovered in the treatment back, account for 98.4%; Unusual 119 examples of AKP before the treatment, normal 117 examples are recovered in the treatment back, account for 98.3%, unusual 124 examples of A before the treatment, normal 122 examples are recovered in the treatment back, account for 98.3%; Unusual 104 examples of G before the treatment, normal 102 examples are recovered in the treatment back, account for 98%; Unusual 14 examples of AFP before the treatment, normal 14 examples are recovered in the treatment back, account for 100%.Each is organized and the results are shown in Table 2 after the liver function index treatment.
Table 2 is respectively organized the result after the treatment of liver function index
Group Total routine number TBIL ALT AKP A G AFP
Unusual before the treatment The treatment back is extensive to get ％ Unusual before the treatment The treatment back is extensive to get ％ Unusual before the treatment The treatment back is extensive to get ％ Unusual before the treatment The treatment back is extensive to get ％ Unusual before the treatment The treatment back is extensive to get ％ Unusual before the treatment The treatment back is extensive to get ％
The honeyed pill group 322 53 53 188 147 146 99.3 45 45 188 48 48 188 34 34 188 5 5 188
The syrup group 290 41 39 97 129 126 97.7 34 32 94.1 39 38 97.4 28 28 188 4 4 188
Capsules group 264 39 38 97.4 116 114 90 40 40 188 37 36 97.2 42 40 95.2 5 5 100
3, virus signature thing: positive 876 examples of HBsAg before the treatment, treatment back 706 turning out cloudy property of example account for 80.3%, positive 842 examples of HBeAg before the treatment, treatment back 816 turning out cloudy property of example account for 96.8%; Positive 854 examples of HBcAb before the treatment, back 850 turning out cloudy property of example treated in the Chinese, accounts for 97.8%.Each is organized hepatitis B replication label therapeutic outcome and sees Table 3.
Table 3 is respectively organized the therapeutic outcome of hepatitis B replication label
Group Total routine number HBsAg HEeAg HBcAb LNA
Positive before the treatment Turn out cloudy after the treatment ％ Positive before the treatment Turn out cloudy after the treatment ％ Positive before the treatment Turn out cloudy after the treatment ％ Positive before the treatment Turn out cloudy after the treatment ％
The honeyed pill group 322 322 288 86.9 307 299 97.4 311 316 99.7 296 290 96
The syrup group 290 298 285 78.7 282 274 97.2 286 284 99.3 263 258 96.1
Capsules group 264 264 221 84 253 243 96.2 257 256 99.6 237 231 97.4
The clinical treatment result of medicine of the present invention shows that also this medicine has following advantage
1, to select genuine Chinese medicine be raw material in invention, and each component meets the pharmaceutical control law regulation.Utilize the comprehensive function treatment hepatitis B effect of each medicine good, body is not had any injury, have no side effect.
2, medicine pure taste of the present invention need not decoct, and taking convenience is easy to carry.And cheap, the medicine source is abundant, helps promoting the use of.
3, medication effect of the present invention is good, and instant effect is stood checking repeatedly.Can fundamentally thoroughly cure hepatitis B, never recurrence after healing.
4, medicine of the present invention is not only cured hepatitis B, and the patient is had the nourishing the human Body effect.Reasonable distribution to the endotrophic material has facilitation.After taking, the patient can make that diet enhancement, weight increase, body constitution strengthen, brace up, the colour of skin is ruddy.

Claims (8)

  1. A kind of Chinese medicine preparation for the treatment of b hepatitis and preparation method thereof
    1, a kind of Chinese patent medicine for the treatment of hepatitis B is characterized in that it is to be made by each raw material of following maximum weight part ratio.
    The Radix Astragali 150 Radix Ginsengs 100 Rhizoma Atractylodis Macrocephalaes 120 Poria 150
    Radix Bupleuri 150 Radix Paeoniae Albas 90 Fructus Aurantii Immaturuss 120 Radix Curcumaes 100
    Radix Salviae Miltiorrhizae 150 Carapax Trionycis 100 Sal Nitri 60 Alumen 60
    Fructus Schisandrae Chinensis 150 Radix Sophorae Tonkinensiss 100 Rhizoma Polygoni Cuspidati 150 Rhizoma Dioscoreae Bulbiferaes 100
    Endothelium Corneum Gigeriae Galli 250 Fructus Hordei Germinatus 200 Fructus Crataegis 120 Radix Et Rhizoma Rhei 90
    Yeast 150.
  2. 2, a kind of Chinese patent medicine for the treatment of hepatitis B is characterized in that it is to be made by each raw material of following optimum weight part ratio.
    The Radix Astragali 100 Radix Ginsengs 60 Rhizoma Atractylodis Macrocephalaes 60 Poria 60
    Radix Bupleuri 100 Radix Paeoniae Albas 60 Fructus Aurantii Immaturuss 60 Radix Curcumaes 60
    Radix Salviae Miltiorrhizae 100 Carapax Trionycis 60 Sal Nitri 60 Alumen 60
    Fructus Schisandrae Chinensis 100 Radix Sophorae Tonkinensiss 60 Rhizoma Polygoni Cuspidati 60 Rhizoma Dioscoreae Bulbiferaes 60
    Endothelium Corneum Gigeriae Galli 100 Fructus Hordei Germinatus 60 Fructus Crataegis 60 Radix Et Rhizoma Rhei 60
    Yeast 100.
  3. 3, a kind of Chinese patent medicine for the treatment of hepatitis B is characterized in that it is to be made by each raw material of following minimum weight part ratio.
    The Radix Astragali 100 Radix Ginsengs 45 Rhizoma Atractylodis Macrocephalaes 45 Poria 60
    Radix Bupleuri 90 Radix Paeoniae Albas 45 Fructus Aurantii Immaturuss 60 Radix Curcumaes 45
    Radix Salviae Miltiorrhizae 90 Carapax Trionycis 45 Sal Nitri 30 Alumen 30
    Fructus Schisandrae Chinensis 90 Radix Sophorae Tonkinensiss 45 Rhizoma Polygoni Cuspidati 60 Rhizoma Dioscoreae Bulbiferaes 45
    Endothelium Corneum Gigeriae Galli 100 Fructus Hordei Germinatus 60 Fructus Crataegis 60 Radix Et Rhizoma Rhei 45
    Yeast 60.
  4. 4,1,2,3 described medicines as requested is characterized in that said medicament is any pharmaceutics and the above any dosage form and preparation method of saying of galenic pharmacy.
  5. 5,, it is characterized in that described pharmaceutical dosage form is a honeyed pill, syrup and capsule according to the described medicine of claim 4.
  6. 6, the compound method of the described medicine honeyed pill of claim 5, it is characterized in that the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, Radix Et Rhizoma Rhei are processed into coarser powder by well-established law, mix with Sal Nitri, Alumen, yeast and to mix thoroughly, be ground into 120 order fine powders, with 25 milliliters in mature vinegar, Rhizoma Zingiberis Recens juice is mixed thoroughly for 50 milliliters, put into wooden case, ferment and take out after 3 days,-12 ℃ of cold preservations 90 minutes, make honeyed pill by well-established law, every ball weighs 12 grams.
  7. 7, the compound method of the described medical syrup of claim 5, it is characterized in that the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Radix Et Rhizoma Rhei, Fructus Crataegi are processed into decoction pieces by well-established law, mix with Sal Nitri, Alumen, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, yeast and to put into the sand jar and decoct with water three times, for the first time add water and cross 6 centimetres of powder, boiled 90 minutes, and took out medicinal liquid; For the second time add water and cross 4 centimetres of powder, boiled 60 minutes, take out medicinal liquid; Add water for the third time and cross 2 centimetres of powder, boiled 30 minutes, take out medicinal liquid.Medicinal residues are mashed as mud, mixed with three medicinal liquids and mix filtration thoroughly, with 20 milliliters in mature vinegar, 30 milliliters of Rhizoma Zingiberis Recens juice are put into marmite, and first intense fire, back slow fire are concentrated into every milliliter and contain 1 gram crude drug amount, add the white sugar of every milliliter 1 gram content, make nourushing syrup.
  8. 8, the compound method of the described medicament capsule of claim 5, it is characterized in that the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Alumen, Sal Nitri, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, 1/2 of each plant demand of Radix Et Rhizoma Rhei, it is standby that yeast consumption whole are ground into 120 order fine powders, again with the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Sal Nitri, Alumen, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, 1/2 of each plant demand of Radix Et Rhizoma Rhei decocts three times.For the first time add water and cross 6 centimetres in face, boiled 90 minutes, take out medicinal liquid; For the second time add water and cross 4 centimetres of powder, boiled 60 minutes, take out medicinal liquid; Add water for the third time and cross 2 centimetres in face, boiled 30 minutes, take out medicinal liquid, mix three times medicinal liquid, with 20 milliliters in mature vinegar, 20 milliliters of Rhizoma Zingiberis Recens juice, filter, medicinal liquid poured in the medicated powder mix thoroughly, pack in the sand jar, build cover, the sand jar is gone in the marmite, add water in the pot,, boiled 60-90 minute with submergence sand jar 2/3 degree of being.Should note allowing water immerse in the jar during steaming and decocting, medicated powder is taken out in the cooling back, incapsulates after the drying, every capsule 0.5 gram.
CN95116034A 1995-10-10 1995-10-10 Chinese drugs for curing hepatitis B Expired - Fee Related CN1058165C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95116034A CN1058165C (en) 1995-10-10 1995-10-10 Chinese drugs for curing hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95116034A CN1058165C (en) 1995-10-10 1995-10-10 Chinese drugs for curing hepatitis B

Publications (2)

Publication Number Publication Date
CN1136939A CN1136939A (en) 1996-12-04
CN1058165C true CN1058165C (en) 2000-11-08

Family

ID=5080743

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95116034A Expired - Fee Related CN1058165C (en) 1995-10-10 1995-10-10 Chinese drugs for curing hepatitis B

Country Status (1)

Country Link
CN (1) CN1058165C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1061885C (en) * 1997-09-18 2001-02-14 李良云 Specific infusion for hepatitis B and producing process thereof
CN1066341C (en) * 1997-10-20 2001-05-30 王兴体 Chinese medicine for treating hepatitis B and preparing process thereof
CN1067267C (en) * 1998-04-24 2001-06-20 汪东平 Medicine for treating hepatitis B
CN101199606B (en) * 2006-12-14 2012-05-09 北京因科瑞斯生物制品研究所 Medicament for treating liver disease
CN103948875A (en) * 2014-05-13 2014-07-30 梁景山 Medicine for treating hepatitis B and preparation method thereof
CN107343948A (en) * 2017-08-04 2017-11-14 成都市飞龙水处理技术研究所 It is a kind of effectively to treat pill medicine of hepatitis B and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1091298A (en) * 1993-02-26 1994-08-31 王旭中 Hepatitis Chinese patent medicine---ganaoling
CN1108943A (en) * 1994-03-21 1995-09-27 李春祥 Medicine "Yigankang" for hepatitis B and its preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1091298A (en) * 1993-02-26 1994-08-31 王旭中 Hepatitis Chinese patent medicine---ganaoling
CN1108943A (en) * 1994-03-21 1995-09-27 李春祥 Medicine "Yigankang" for hepatitis B and its preparation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
《新中医》21(9) 1989.9.30 金克畅，清肝解毒汤治疗HBSAG阳性87例报告 *
《湖南医科大学学报》29(2) 1994.2.28 李广勋等，神农口服液调节免疫功能及抗衰老作用的研究 *
《福建中医药》25(2) 1994.2.28 金志春等，茵陈硝矾胶囊治疗急性黄疸型病毒型肝炎的疗效观察253例 *
《福建中医药》25(2) 1994.2.28 金志春等，茵陈硝矾胶囊治疗急性黄疸型病毒型肝炎的疗效观察253例;《湖南医科大学学报》29(2) 1994.2.28 李广勋等，神农口服液调节免疫功能及抗衰老作用的研究;《新中医》21(9) 1989.9.30 金克畅，清肝解毒汤治疗HBSAG阳性87例报告 *

Also Published As

Publication number Publication date
CN1136939A (en) 1996-12-04

Similar Documents

Publication Publication Date Title
CN1044974C (en) Anti- hepatitis B preparation
CN1047946C (en) Preparation for treating senile diseases
CN1194843A (en) Method for producing green health medicine
CN1354014A (en) Gongbu ointment
CN1255181C (en) Preparation of medicinal composition for nourishing
CN1183919C (en) Cancer treating medical composition
CN1058165C (en) Chinese drugs for curing hepatitis B
CN1082376C (en) Pathogenic factor eliminating and healthy energy supporting anticancer medicine
CN109248305A (en) A kind of Chinese medicine composition and preparation method thereof for treating liver fibrosis
CN100340286C (en) Medicine for treating hepatitis B and its preparing method
CN1111046C (en) Chinese medicine preparation for curing postpartum disease of woman
CN100360156C (en) Chinese medicine composition new use
CN1059104C (en) Capsule for anti hepatitis B
CN1130529A (en) Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof
CN111000969A (en) Pharmaceutical composition for treating simple obesity and preparation method thereof
CN1062176C (en) Oral liquid for curing cancer
CN1195541C (en) Medicine combination for treating chronic hepatitis B
CN101015636A (en) Novel use of Chinese-medicinal composition
CN1899574A (en) Chinese medicine composition for preventing and controlling liver cancer and its use
CN1061249C (en) Quick-acting traditional Chinese medicine for curing hepatitis B
CN111375036B (en) Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application thereof
CN1151813C (en) Traditional Chinese medicine composition for curing insomnia
CN1113804A (en) Antianemic powder and its preparing method
CN1836705A (en) Medicine for treating amblyopia and its preparing method
CN1244339C (en) Chinese medicine for treating and preventing fatty liver and its preparing process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee